找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibacterial Therapy: Achievements, Problems and Future Perspectives; W.-D. Busse,H. Labischinski,H.-J. Zeiler Conference proceedings 199

[復(fù)制鏈接]
查看: 29721|回復(fù): 40
樓主
發(fā)表于 2025-3-21 20:07:51 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Antibacterial Therapy: Achievements, Problems and Future Perspectives
影響因子2023W.-D. Busse,H. Labischinski,H.-J. Zeiler
視頻videohttp://file.papertrans.cn/159/158394/158394.mp4
圖書封面Titlebook: Antibacterial Therapy: Achievements, Problems and Future Perspectives;  W.-D. Busse,H. Labischinski,H.-J. Zeiler Conference proceedings 199
影響因子At a symposium in Wuppertal held on 26 September 1995, Dr. Karl-Georg Metzger was honored, on the occasion of his retirement, for his scientific contributions and involvement in antibacterial drug research and develop- ment within Bayer AG. In 1963 Dr. Metzger was the first "molecular micro- biologist" to join Bayer in the field of antibacterial research. Karl-Georg Metzger studied physics and biology at the University of Mainz from 1950 to 1953 and continued his scientific education, with a grant from the Deutsche Forschungsgemeinschaft, in Frankfurt on Main (1953-1956). From 1956 to 1958, under Professor Kaplan, he worked on his DNA following treatment of PhD, studying on "Energy conduction along bacteria with UV light and X-rays and the formation of mutations". He was awarded his PhD in 1959. From 1958 to 1963 he was research assistant in ra- diobiology development at the Institute of Genetics in Cologne. During the following years he became fascinated by the emerging fields of molecular biology and gene technology. He worked together with the molecular gen- eticists W. Harms and M. Delbriick, who built up one of the most renowned institutes in the world, in Cologne. ‘‘An incred
Pindex Conference proceedings 1997
The information of publication is updating

書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives影響因子(影響力)




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives影響因子(影響力)學(xué)科排名




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives網(wǎng)絡(luò)公開度




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives被引頻次




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives被引頻次學(xué)科排名




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives年度引用




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives年度引用學(xué)科排名




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives讀者反饋




書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:51:00 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:49:50 | 只看該作者
Prinzipien der Programmentwicklung,etic parameters: oral, parenteral, infusion, bolus injection, the amount of drug, frequency of dosing, and duration of therapy. It is questionable whether such simple calculation (MIC and concentration in the serum) can describe antimicrobial activity. The pharmacokinetic data, usually available as
地板
發(fā)表于 2025-3-22 06:11:21 | 只看該作者
5#
發(fā)表于 2025-3-22 12:17:49 | 只看該作者
Antibacterial Therapy: Achievements, Problems and Future Perspectives
6#
發(fā)表于 2025-3-22 16:11:55 | 只看該作者
Antibacterial Therapy: Achievements, Problems and Future Perspectives978-3-642-60803-2
7#
發(fā)表于 2025-3-22 21:01:43 | 只看該作者
Staphylococci, Nosocomial Infections, and the Magic Ring, the very beginning of the antibiotic epoch, this ring had something magical. The use of the ring by physicians resulted in the cure of many of the bacterial infections, which were the big killer diseases in medicine before the time of specific antimicrobial chemotherapy. It was thought that with th
8#
發(fā)表于 2025-3-22 23:07:43 | 只看該作者
Expanding and Preserving the Utility of Quinolone Antimicrobials,was the first broad-spectrum fluoroquinolone to be used successfully to treat infections outside the genitourinary tract. The increasing problem of resistance to other classes of antimicrobial agents has contributed to the need for and value of current fluoroquinolones such as ciprofloxacin. In part
9#
發(fā)表于 2025-3-23 04:57:03 | 只看該作者
Pharmacodynamics of Antibiotics,etic parameters: oral, parenteral, infusion, bolus injection, the amount of drug, frequency of dosing, and duration of therapy. It is questionable whether such simple calculation (MIC and concentration in the serum) can describe antimicrobial activity. The pharmacokinetic data, usually available as
10#
發(fā)表于 2025-3-23 09:25:56 | 只看該作者
Pharmacoeconomic Research with Antibacterials,, especially within the pharmaceutical industry, have begun to study the economic impact of medicines on health care provision on a micro- and macroeconomic level. The new field of research, pharmacoeconomics, has grown at a tremendous rate, supplying ample evidence of the economic benefits of moder
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 07:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
同心县| 麻城市| 曲沃县| 英德市| 文昌市| 武夷山市| 昌平区| 大化| 霍州市| 永靖县| 五大连池市| 嘉鱼县| 宕昌县| 海口市| 拉孜县| 新乡市| 遵义县| 宁强县| 杂多县| 历史| 东光县| 株洲市| 兴义市| 湟源县| 霍林郭勒市| 北流市| 玉树县| 且末县| 裕民县| 巫溪县| 霍邱县| 鄂尔多斯市| 普陀区| 瑞丽市| 芦山县| 临沭县| 桦甸市| 绥化市| 铁岭市| 鲜城| 鄢陵县|